Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is known as a highly aggressive malignant disease. Prognosis for patients is notoriously poor, despite improvements in surgical techniques and new (neo)adjuvant chemotherapy regimens. Early detection of PDAC may increase the overall survival. It is furthermore...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Hanna-Sawires, Randa G., Schiphuis, Jorinde H., Wuhrer, Manfred, Vasen, Hans F. A., van Leerdam, Monique E., Bonsing, Bert A., Mesker, Wilma E., van der Burgt, Yuri E. M., Tollenaar, Rob A. E. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961509/
https://ncbi.nlm.nih.gov/pubmed/33800786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22052655
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares